Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Alicja Urbaniak

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
10
2023
1171
2.070
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
2022
92
1.940
Why?
Pyrans
5
2021
22
1.900
Why?
Antineoplastic Agents, Phytogenic
3
2021
69
1.430
Why?
Colchicine
5
2021
28
1.390
Why?
Pharmacogenetics
1
2023
52
0.900
Why?
Polyporaceae
1
2023
3
0.880
Why?
Mitosis
4
2022
91
0.860
Why?
Cell Line, Tumor
10
2023
1403
0.850
Why?
Breast Neoplasms
3
2021
1174
0.820
Why?
Induced Pluripotent Stem Cells
1
2022
42
0.800
Why?
Cell Proliferation
9
2023
1007
0.770
Why?
Glioblastoma
1
2022
92
0.750
Why?
Esters
2
2018
22
0.740
Why?
Antibiotics, Antineoplastic
1
2021
78
0.730
Why?
Paclitaxel
1
2020
84
0.730
Why?
Neoplastic Stem Cells
1
2021
103
0.720
Why?
Melanoma
1
2023
285
0.710
Why?
Carbamates
1
2020
16
0.710
Why?
Antioxidants
2
2019
249
0.690
Why?
Drug Screening Assays, Antitumor
7
2021
136
0.670
Why?
Carcinoma, Ductal, Breast
1
2020
89
0.670
Why?
Brain Neoplasms
1
2022
287
0.650
Why?
Lythraceae
1
2018
2
0.640
Why?
Plant Extracts
1
2020
190
0.600
Why?
MCF-7 Cells
4
2021
68
0.600
Why?
Iron
1
2018
122
0.590
Why?
Stilbenes
1
2017
62
0.560
Why?
Exercise
1
2018
495
0.470
Why?
Apoptosis
5
2023
1101
0.470
Why?
Cell Survival
6
2021
600
0.430
Why?
Drug Discovery
2
2023
85
0.400
Why?
Vincristine
2
2022
89
0.390
Why?
Humans
19
2023
49974
0.380
Why?
Amides
3
2020
34
0.370
Why?
Monensin
2
2022
12
0.370
Why?
Cell Death
2
2020
181
0.310
Why?
Athletes
2
2019
103
0.310
Why?
Molecular Docking Simulation
4
2021
73
0.310
Why?
Tubulin Modulators
4
2020
31
0.290
Why?
Double-Blind Method
2
2019
681
0.290
Why?
Gonadotrophs
1
2023
21
0.220
Why?
Tamoxifen
1
2023
60
0.220
Why?
Mycelium
1
2023
3
0.220
Why?
Trametes
1
2023
4
0.220
Why?
Structure-Activity Relationship
3
2021
395
0.220
Why?
Dose-Response Relationship, Drug
4
2021
1376
0.210
Why?
Microtubules
2
2022
41
0.210
Why?
Organoids
1
2022
39
0.210
Why?
Benzoxazines
1
2021
18
0.200
Why?
Sarcoma, Ewing
1
2021
27
0.190
Why?
Morpholines
1
2021
71
0.190
Why?
Receptor, Cannabinoid, CB2
1
2021
58
0.190
Why?
Tissue Culture Techniques
1
2020
40
0.190
Why?
Tumor Microenvironment
1
2022
212
0.190
Why?
Naphthalenes
1
2021
121
0.180
Why?
Cell Division
1
2021
292
0.180
Why?
Molecular Structure
2
2021
297
0.180
Why?
Colchicum
1
2020
4
0.180
Why?
Receptor, Cannabinoid, CB1
1
2021
125
0.180
Why?
Cell Movement
1
2021
247
0.180
Why?
Inhibitory Concentration 50
1
2020
76
0.180
Why?
Cannabinoids
1
2021
105
0.180
Why?
Receptors, Estrogen
1
2020
130
0.170
Why?
G1 Phase
1
2018
14
0.170
Why?
Urethane
1
2018
6
0.160
Why?
Ergometry
1
2018
4
0.160
Why?
Fruit
1
2019
136
0.160
Why?
Poly(ADP-ribose) Polymerases
1
2018
30
0.150
Why?
DNA Fragmentation
1
2018
55
0.150
Why?
Aniline Compounds
1
2018
43
0.150
Why?
G1 Phase Cell Cycle Checkpoints
1
2017
17
0.150
Why?
Neoplasms
4
2020
1235
0.150
Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
129
0.140
Why?
Interleukin-6
1
2018
264
0.140
Why?
Sulfonamides
1
2018
129
0.140
Why?
Female
4
2021
26472
0.140
Why?
Randomized Controlled Trials as Topic
1
2019
549
0.140
Why?
Tumor Suppressor Protein p53
1
2018
202
0.140
Why?
Dietary Supplements
1
2019
443
0.130
Why?
Drug Design
3
2020
120
0.120
Why?
Time Factors
1
2020
2903
0.120
Why?
Muscle, Skeletal
1
2019
750
0.110
Why?
Halogenation
2
2020
6
0.090
Why?
Cell Cycle
2
2022
231
0.080
Why?
Tubulin
2
2019
23
0.080
Why?
Young Adult
1
2018
3958
0.080
Why?
Cells, Cultured
2
2021
1573
0.070
Why?
Adult
1
2022
13236
0.070
Why?
Middle Aged
1
2020
12069
0.060
Why?
Follicle Stimulating Hormone
1
2023
43
0.060
Why?
bcl-2-Associated X Protein
1
2022
56
0.050
Why?
Caspase 3
1
2022
97
0.050
Why?
Cytotoxins
1
2021
16
0.050
Why?
Mice
2
2023
5739
0.050
Why?
Carrier Proteins
1
2023
304
0.050
Why?
Binding, Competitive
1
2021
94
0.050
Why?
Enzyme Activation
1
2022
276
0.050
Why?
Protein Biosynthesis
1
2023
253
0.050
Why?
Ligands
1
2021
204
0.050
Why?
Mice, Inbred BALB C
1
2021
304
0.040
Why?
RNA, Messenger
1
2023
1105
0.040
Why?
Molecular Conformation
1
2019
67
0.040
Why?
Male
1
2018
25241
0.040
Why?
HeLa Cells
1
2018
250
0.040
Why?
Tumor Cells, Cultured
1
2018
465
0.040
Why?
Models, Molecular
1
2018
338
0.040
Why?
Animals
2
2023
13187
0.040
Why?
Aged
1
2018
9310
0.020
Why?
Urbaniak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description